Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis


Çelik S., Kaynar L.

Journal of Current Hematology & Oncology Research, cilt.2, sa.1, ss.20-21, 2024 (Hakemli Dergi)